![](/img/cover-not-exists.png)
O1-2-4Global phase III trial of comparing mXELIRI+BV vs FOLFIRI+Bmab for 2nd line mCRC (AXEPT) Japanese population analysis
Kato, Takeshi, Kagawa, Yoshinori, Ota, Mitsuyoshi, Makiyama, Akitaka, Denda, Tadamichi, Matsuda, Chu, Yamada, Yasuhide, Iwasa, Satoru, Won Kim, Tae, Xu, Rui-hua, Suk Park, Young, Morita, Satoshi, SakaVolume:
29
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy374.001
Date:
October, 2018
File:
PDF, 94 KB
2018